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INTRUCTION
Yacon contains a large amount of non-digestible oligosaccharide called inulin that belongs to a class of carbohydrates known as fructans 1 . Inulin-type fructans (ITF) can produce butyrate and decreases the rate of aberrant crypt foci (ACF), a pre-neoplastic lesion found in colon 2 . Butyrate modulates gene transcription by inhibiting histone deacetylases (HDAC) 2 . Cancer cells appear to be more sensitive than non-transformed cells to HDAC inhibitory compounds. In addition, the yacon ITF promotes satiety and retard the absorption of foodderived energy via reducing a gastrointestinal peptide-ghrelin that is a growth hormone secretagogue 3;4 . Reduction of serum ghrelin results in decreases of IGF-1 5 . Subsequently, the PI3K/Akt-mTOR signaling pathway will be inactivated via increasing AMPK activity and its downstream events, inhibition of cell proliferation and induction of cell apoptosis will be observed. However, few studies have been shown the effect of the ITF on breast cancer. The hypotheses were that treatment with yacon will: 1) dose-dependently reduce the incidence and multiplicity of chemically-induced pre-malignant and malignant mammary tumors in rats, 2) increase butyrate and decrease ghrelin and insulin-like growth factor 1 (IGF-1) in the blood, 3) inhibit HDAC, and downregulate Akt-mammalian target of rapamycin (mTOR) signaling pathway through upregulated AMP activated kinase (AMPK) -a energy metabolic sensor, eventually decreasing cell proliperation and increasing apoptosis. Objective were: 1) To determine mammary carcinogenic responses to yacon in experimental animals. 2) To evaluate the association of the circulating mediator, gastrointestinal peptide, and growth factors with the carcinogenic responses in rats fed dietary yacon. 3) To determine the HDAC and identify AMPK/Akt-mTOR cell signaling pathway that were downstream targets of HDAC and ghrelin-IGF1 axis. Mammary carcinogenesis was initiated by injection of female rats with 50 mg of 1-methyl-1-nitrosourea/kg body weight (i.p.) at 21 days of age. One week later, the rats were fed diets containing yacon powder at 0%, 15%, 30% or 60% (30 rats/group) for 8 weeks, respectively. Rats were palpated for mammary tumors and effects of yacon on the incidence, multiplicity and latency of mammary carcinomas were evaluated. Plasma was collected to determine blood glucose, insulin, leptin, butyrate, ghrelin, and IGF-1 as well as inflammatory factors. The tumor and liver tissues were used for histological evaluation and molecular biological assessments including HDAC and regulators that were associated with AMPK/Akt-mTOR pathway in mammary gland pathologies. Differences between diet groups were statistically analyzed by ANOVA, Chi-Square, survival and correlation analyses. Yacon can be readily introduced into the food supply for some specific cancer prevention and retard recuration since it has been in the market. The study will provide crucial biological information to complement the knowledge of natural functional foods that is relevant to a number of foods rich in nondigestible, fermentable oligosaccharides. Consequently, the new type of functional food will significantly contribute to the goal of proventing initiation of breast cancer and reduce survivor recuration because it is natural, tolerantable and acceptable for the clinic patients and general population in aditional to benefit to obesity, diabetes II and cadiovascular diseases. One hundred twenty female Sprague Dawley rats were obtained at 20 days of age. They were injected with MNU (50 mg/kg body weight) at 21 days of age as previously described by us 6 . Following carcinogen administration, rats were randomized to one of four diet groups and 30 rats per group: AIN 93G (control) or AIN 93G supplemented with 150 g, 300 g or 600 g of yacon root powder/kg diet. Inulin concentration in the yacon is 4.66 g/100 g, which was analyzed by Warren Analytical Laboratory (Greeley, CO). The dose of 15% -60% dietary yacon provided 0.7% -2.8% of inulin-type fructans in diet) is about 0.5 -2.0 g inulin-type fructans/kg body weight rat, which is the acceptable dose for human. Experimental diets were fed to the rats beginning one week post carcinogen administration in order to determine the inhibitory effect of yacon on promotion and progression of mammary carcinogenesis. All of rats were housed three per cage and weighed 1-2 times per week. At the end of study, no significant difference was observed in the final body among 4 dietary groups (ANOVA, P=0.165, see figure and table 1 in supporting data section). The average of body weight is 225, 222, 217 or 215 gram for groups of control, 15%, 30% or 60% yacon. From three weeks of post carcinogen until study termination, rats were palpated twice per week for detecting mammary tumors. A log was kept of all detected tumors and their locations. Experiment was terminated at 9 week of post carcinogen. At necropsy, the log was used to record all grossly visible tumors and to assist with confirmation of all palpable tumors. All tumors detected at necropsy were excised and weighed. One portion of excised tumors was processed for histological classification and the remainder part of each tumor was snap-frozen in liquid nitrogen and were available for the proposed mechanistic studies in Task 3. Abdominal-inguinal mammary glands from both sides of animal were excised. One side were spread out on a glass and fixed in 10% formalin and another side were spread out on a film, which was sealed in a bag and snap-frozen in liquid nitrogen for molecular analysis (in Aim 3). Liver was also excised and snap-frozen in liquid nitrogen. At the end of this experimental period, the samples for all of the Tasks were collected and stored at -80ºC for further analyses. b. Process mammary glands and mammary tumors for the histological and immunohistological evaluations. All mammary glands whole mounts were stained for further analysis. All tumors excised at necropsy were processed for histological classification. Briefly, all lesions were put in cassettes individually. The cassettes were processed through toluene and molten paraffin. Then, the lesions were embedded in paraffin and cut at 4 um sections that were placed onto glass microscope slides. Sections were heat immobilized and then stained using an H&E protocol. At the end of this experimental period, all of slides were stained and ready for further evaluation. c. Evaluate the mammary lesions histologically and summarize the mammary carcinogenic responses to dietary yacon. All of the tumors were stained by H&E and were histologically diagnosed under microscope. The tumors that were detectable by palpation and that were histologically confirmed to be mammary adenocarcinoma (AC) were summarized to produce the incidence, multiplicity, weight and latency curves. At the end of this period, we found that palpated cancer incidence was significantly reduced by dietary yacon (Chi-square test, p=0.05) while multiplicity (palpated cancer number/rat) was not significantly different among 4 groups (Kruskal-Walls Test, p=0.247). The cancer weight was significantly lower in 30% yacon group (Kruskal-Walls Test, compared to control, p=0.035; compared to 15% yacon group, p=0.033). Latency of palpated carcinomas was delayed by dietary yacon (p=0.07, Mantel test, see figure 2 and table 1 in supporting data section).
Task 2. To evaluate the association of circulating mediator, gastrointestinal peptide, and growth factors with the carcinogenic responses in rats fed dietary yacon (month 7-9). Blood samples were collected at necropsy for the evaluation of circulating butyrate, ghrelin, IGF-1, glucose, insulin, leptin, and inflammatory factors from the study described in Task 1. a. Determine the circulating mediator -butyrate. Butyrate will be determined by gas chromatography and the assays are on the way. b. Determine plasma gastrointestinal pepide -ghrelin.
Plasma active ghrelin was determined and no significant difference was observed among 4 groups (P=0.753, ANOVA) (see figure 3 and table 2 in supporting data section). c. Determine serum growth factors -Glucose, insulin, leptin, IGF-1, and inflammatory figure 3 and table 2 in supporting data section) d. Summarize the data and identify the association of all circulating factors with the carcinogenic response to dietary yacon. At the end of this period, the effect of dietary yacon on the levels of circulating glucose, insulin, leptin, ghrelin, IGF-1 and inflammatory factors were ascertained. And the association between circulating factors (glucose, insulin, leptin, ghrelin, and IGF-1) and the carcinogenic responses (the incidence and multiplicity of adenomas) were identified. As expected, the incidence, multiplicity and weight of mammary carcinomas were significantly positive-correlated to each other. These carcinogenic responses were also positive-correlated to plasma IL-6. And, the carcinogenic responses were significantly negative-correlated to the latency of the carcinomas as well as to plasma glucose, IL-6 and TNFα (p<0.001) while no significant correlation was observed between carcinogenic responses and other circulating factors. However, significant correlations were observed among the circulating factors, which were positive correlations between insulin and IGF-1, leptin, or glucose as well as between C-reactive protein and IGF-1 or leptin (p<0.01), also between IL-6 and C-reactive protein or IGF-1; and negative correlations between leptin and active ghrelin (p<0.01). (see table 3 in supporting data section) Task 3. To determine the HDAC and identify cell signaling pathway that were downstream targets of HDAC and ghrelin-IGF1 axis.
a. Determine the protein levels of HDAC, PI3K, Akt, mTOR and other related regulators in PI3K/Akt-mTOR pathway.
Frozen mammary gland, mammary tumors and liver of control and 30% yacon groups collected under Task 1 were homogenized for determining the levels of HDAC, Akt, mTOR, AMPK by western blotting. It has been observed that HDAC in all of three tissues were decreased in 30% yacon group compared the control group. Significant reduction was observed in both mammary and mammary carcinomas (p<0.05). There was no significant difference in Akt and AMPK of three tissues between control and yacon group. However, phosphorylated mTOR and mTOR were significantly decreased in mammary carcinomas of 30% yacon group to compared with the control group (p<0.0001) while only mTOR was significantly reduced in mammary gland of 30% yacon group. (see figure 4 and table 4 in supporting data section) b. Summarize the data and identify the regulations of HDAC and Akt-mTOR/AMPK pathway by HADC and ghrelin-IGF1 axis.
The current data suggest that dietary yacon inhibits HDAC and downregulates mTOR signaling pathway in mammary gland and mammary carcinomas. The changes were more obvious in the mammary tumors than in the mammary gland. In addition, the reduction of plasma IL-6, TNFα and C-reactive protein by dietary yacon suggests that yacon has impact on inflammation. Further investigation will focus on yacon anti-inflammation effect and its association with the inhibition of breast cancer in high inflammatory status, such as metabolic syndrome in women and in pre-clinical animal model.
Taken together, our data indiate that yacon shows inhibitory effect on the promotion and progression of chemically-induced mammary carcinogenesis in rat. The inhibition is assicoated with downregulation of IGF-1/HDAC/Akt/mTOR signaling pathway and with anti-inflammation.
KEY RESEARCH ACCOMPLISHMENTS
• Dietary yacon reduced the promotion and progression of mammary carcinogenesis in rat.
• The inhibition is assicoated with downregulation of IGF-1/HDAC/Akt/mTOR signaling pathway, and with anti-inflammation .
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REPORTABLE OUTCOMES
• Presentation: The current results will be presentated at 9 th Annual AACR International Conference on Frontiers in Cancer Prevention Research (November 7-10, 2010, Pennsylvania Convention Center, Philadelpha, PA).
• Paper: A manusscript titled "Effect of Dietary Yacon on Promotion and Progression of ChemicallyInduced Mammary Carcinogenesis in Rat" will be submitted to Cancer Prevention Resaerch.
CONCLUSION
Results showed that dietary yacon potentially reduced the promotion and progression of chemically-induced mammary carcinogenesis in rat, which is associated with downregulation of IGF-1/HDAC/Akt/mTOR signaling pathway and with anti-inflammation. Future work will focus on the effect of yacon on obesity and antiinflammation, which are key risk factors for breast cancer. 
